Form 8-K - Current report:
SEC Accession No. 0001104659-22-056435
Filing Date
2022-05-05
Accepted
2022-05-05 16:01:50
Documents
13
Period of Report
2022-05-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2213708d1_8k.htm   iXBRL 8-K 63402
2 EXHIBIT 10.1 tm2213708d1_ex10-1.htm EX-10.1 121003
  Complete submission text file 0001104659-22-056435.txt   384856

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gild-20220504.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20220504_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20220504_pre.xml EX-101.PRE 22591
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2213708d1_8k_htm.xml XML 3488
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 22896038
SIC: 2836 Biological Products, (No Diagnostic Substances)